Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Randomized Phase II Study Evaluating the Efficacy and Safety of Deferasirox Versus Deferoxamine in Patients with Sickle Cell Disease (SCD): 2-Year Results Including Pharmacokinetics (PK) and Safety of Deferasirox with Concomitant Hydroxyurea Therapy

Elliott Vichinsky, MD, Marcela Torres, MD, Jonathan Glass, MD, Caterina P Minniti, MD, Stéphane Barrette, MD, Dany Habr, MD, Nicola Lynch, MS, Yiyun Zhang, Beatrice Files, MD

Blood (2011) 118 (21): 1082.

https://doi.org/10.1182/blood.V118.21.1082.1082

Published: 2011

Journal Articles

Spleen Function in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial.

Zora R. Rogers, MD, Renee C. Rees, PhD, Beatrice Files, MD, Rathi V. Iyer, MD, Barry L. Shulkin, MD, Eglal Shalaby-Rana, MD, John H. Miller, MD, Stephen D. Dertinger, PhD, Peter A. Lane, MD, Winfred C. Wang, MD, Russell E. Ware, MD, PhD, The BABY HUG Investigators

Blood (2008) 112 (11): 1416.

https://doi.org/10.1182/blood.V112.11.1416.1416

Published: 2008

Journal Articles

Candidate Gene Polymorphisms and Their Association with TCD Velocities in Children with Sickle Cell Disease.

Abdullah Kutlar, MD, Donald Brambilla, PhD, Betsy Clair, Anne Haghighat, Sule Bakanay, MD, Gaye Adams, MD, Ferdane Kutlar, MD, Virgil McKie, MD, Beatrice Files, MD, Gerald Woods, MD, Melanie Kirby, MD, Elliott Vichinsky, MD, Clark Brown, MD, Charles Scher, MD, Robert Adams, MD

Blood (2007) 110 (11): 429.

https://doi.org/10.1182/blood.V110.11.429.429

Published: 2007

Journal Articles

Evaluation of Chronic Transfusion (Tx) Practices in Children with Sickle Cell Disease (SCD): A Survey of STOP II Investigators.

Ofelia Alvarez, Scott Miller, Brian Berman, Clark Brown, James Casella, Thomas Coates, Charles Daeschner, Beatrice Files, Janet Kwiatkowski, Margaret Lee, Winfred Wang, Gerald Woods

Blood (2004) 104 (11): 3732.

https://doi.org/10.1182/blood.V104.11.3732.3732

Published: 2004

Journal Articles

Stroke risk in siblings with sickle cell anemia

M. Catherine Driscoll, Anne Hurlet, Lori Styles, Virgil McKie, Beatrice Files, Nancy Olivieri, Charles Pegelow, Brian Berman, Richard Drachtman, Kantilal Patel, Donald Brambilla

Blood (2003) 101 (6): 2401–2404.

https://doi.org/10.1182/blood.V101.6.2401

Published: 2003

NARROW

A Randomized Phase II Study Evaluating the Efficacy and Safety of Deferasirox Versus Deferoxamine in Patients with Sickle Cell Disease (SCD): 2-Year Results Including Pharmacokinetics (PK) and Safety of Deferasirox with Concomitant Hydroxyurea Therapy

Spleen Function in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial.

Candidate Gene Polymorphisms and Their Association with TCD Velocities in Children with Sickle Cell Disease.

Evaluation of Chronic Transfusion (Tx) Practices in Children with Sickle Cell Disease (SCD): A Survey of STOP II Investigators.

Stroke risk in siblings with sickle cell anemia

Email alerts

ASH Publications

American Society of Hematology

A Randomized Phase II Study Evaluating the Efficacy and Safety of Deferasirox Versus Deferoxamine in Patients with Sickle Cell Disease (SCD): 2-Year Results Including Pharmacokinetics (PK) and Safety of Deferasirox with Concomitant Hydroxyurea Therapy

Spleen Function in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial.

Candidate Gene Polymorphisms and Their Association with TCD Velocities in Children with Sickle Cell Disease.

Evaluation of Chronic Transfusion (Tx) Practices in Children with Sickle Cell Disease (SCD): A Survey of STOP II Investigators.

Stroke risk in siblings with sickle cell anemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only